In the pharmaceutical sector, cost and revenue pressures have led to surging demand for outsourced services. Those services touch each phase of the pharma value chain and are creating significant growth opportunities for a wide range of businesses, including consulting firms, analytics and data platforms, marketing and communications providers, and commercialization platforms.
These opportunities have also attracted the attention of investors, making pharma services an active area in the healthcare M&A market, with public valuations currently exceeding pre-COVID-19 levels.
In this new report, we focus on pharma commercialization services, sharing essential details such as:
- End Markets
- M&A Activity
- Market Landscape, Segmentation and Competitive Landscape
- Key Value Drivers and Differentiators
Please complete this form to get the report.